PROTEINURIA
Clinical trials for PROTEINURIA explained in plain language.
Never miss a new study
Get alerted when new PROTEINURIA trials appear
Sign up with your email to follow new studies for PROTEINURIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cancer patients: Kidney-Sparing drug shows promise
Disease control Not yet recruitingThis study tests a drug called sparsentan to reduce high levels of protein in the urine (proteinuria) caused by certain cancer treatments. About 20 adults with cancer who are taking VEGF inhibitors and have developed proteinuria will receive sparsentan for 8 weeks. The goal is to…
Matched conditions: PROTEINURIA
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a traditional chinese granule ease a common cancer treatment side effect?
Symptom relief Not yet recruitingThis study tests whether adding Huaier Granule to standard care can reduce proteinuria (excess protein in urine) in breast cancer patients who developed it as a side effect of immunotherapy or anti-angiogenic therapy. About 120 women will be randomly assigned to receive either st…
Matched conditions: PROTEINURIA
Phase: PHASE2 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a herbal remedy fix kidney side effects of cancer drugs?
Symptom relief Not yet recruitingThis study tests whether Huaier Granules, a traditional Chinese medicine, can reduce proteinuria (excess protein in urine) caused by the cancer drugs bevacizumab or anlotinib in lung cancer patients. About 40 adults will be enrolled and followed for 16 weeks to see if the granule…
Matched conditions: PROTEINURIA
Phase: PHASE4 • Sponsor: Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Computer alert aims to catch kidney disease early
Knowledge-focused Not yet recruitingThis study tests whether an electronic health record alert can help primary care doctors refer patients with blood and protein in their urine to a kidney specialist. About 1,200 adults with these high-risk signs will be included. The goal is to see if the alert improves referral …
Matched conditions: PROTEINURIA
Phase: NA • Sponsor: Geisinger Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study to map Real-World use of iptacopan in rare kidney disease
Knowledge-focused Not yet recruitingThis study looks back at medical records of about 83 adults with C3 glomerulopathy (C3G), a rare kidney disease, who are taking the drug iptacopan. Researchers will describe patients' health history, lab results, and how their disease changes over a year of treatment. The goal is…
Matched conditions: PROTEINURIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC